Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Pharmacopsychiatry

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    June 2022
  1. ESEN-SEHIR D, Kopf J, Hagele S, Plichta MM, et al
    Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Pharmacopsychiatry. 2022 Jun 22. doi: 10.1055/a-1811-7241.
    PubMed     Abstract available


    May 2022
  2. MIURA G, Tanaka K, Kemuriyama T, Misawa F, et al
    Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review.
    Pharmacopsychiatry. 2022 May 5. doi: 10.1055/a-1811-7318.
    PubMed     Abstract available


    January 2022
  3. VEERMAN SRT, Bogers JPAM, Cohen D, Schulte PFJ, et al
    COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.
    Pharmacopsychiatry. 2022;55:48-56.
    PubMed     Abstract available


    May 2021
  4. SPOOV J, Bredbacka PE
    Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 microg i.v. TRH.
    Pharmacopsychiatry. 2021 May 12. doi: 10.1055/a-1481-9058.
    PubMed     Abstract available


    February 2021
  5. SHI H, Guan XN, Liu DY, Zhu L, et al
    Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study.
    Pharmacopsychiatry. 2021 Feb 24. doi: 10.1055/a-1353-6544.
    PubMed     Abstract available


    January 2021
  6. SAKURAI H, Yasui-Furukori N, Suzuki T, Uchida H, et al
    Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus.
    Pharmacopsychiatry. 2021 Jan 12. doi: 10.1055/a-1324-3517.
    PubMed     Abstract available


    December 2020
  7. GRUNDER G, Bauknecht P, Klingberg S, Leopold K, et al
    Treatment Goals for Patients with Schizophrenia - A Narrative Review of Physician and Patient Perspectives.
    Pharmacopsychiatry. 2020 Dec 8. doi: 10.1055/a-1298-4546.
    PubMed     Abstract available


    October 2020
  8. ZHANG T, Wang J, Xu L, Wei Y, et al
    Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission.
    Pharmacopsychiatry. 2020 Oct 12. doi: 10.1055/a-1252-2942.
    PubMed     Abstract available


    August 2020
  9. WAGNER E, Oviedo-Salcedo T, Pelzer N, Strube W, et al
    Effects of Smoking Status on Remission and Metabolic and Cognitive Outcomes in Schizophrenia Patients Treated with Clozapine.
    Pharmacopsychiatry. 2020 Aug 5. doi: 10.1055/a-1208-0045.
    PubMed     Abstract available


    July 2020

  10. "Peter Muller Preis fur Forschung im Bereich Schizophrenie" in Hohe von 5.000euro.
    Pharmacopsychiatry. 2020;53:194.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: